FDA calls for comments on artificial intelligence in drug manufacturing
Blog
Cortex - Life Sciences Insights
On March 1, 2023, FDA’s Center for Drug Evaluation and Research (CDER) published a Discussion Paper on artificial intelligence (AI) in drug…
Popular articles from this firm
